(Q37412812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

23 January 2020

main subject

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Helena Teede

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

2

Helena Teede

1 reference

20 August 2017

Lisa Moran

1

1 reference

20 August 2017

publication date

11 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

Human Reproduction Update

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

477-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279045%20AND%20SRC:MED&resulttype=core&format=json

Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin responses to the oral glucose tolerance test in women of different ethnicity with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Polycystic ovaries in Hirsute women with normal menses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Abdominal adiposity and the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS)--an extended critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The prevalence of polycystic ovaries in women with infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Impaired carotid viscoelastic properties in women with polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin and risk of cardiovascular disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The management of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008

Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMP008